Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuropa Study of sugammadex versus neostigmine for postoperative oxygenation in the PACU
NL-OMON40831Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Oct 2014
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Trial of Sugammadex, neostigmine and rocuronium (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Oxygen saturation. Started Oct 2014; status: active, not recruiting.
02
Drugs
Sugammadexneostigminerocuronium
Beyond the preview
Go deeper on NL-OMON40831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40831.